Enhanced antileukemic effect of NKp30b isoform of donor-derived NK cells infused after HLA-haploidentical allogeneic hematopoietic cell transplantation in high-risk AML and MDS.
- DOI
- 10.1038/s41409-025-02518-0
- Published
- 2025 Apr
- Container
- Bone marrow transplantation
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41409-025-02518-0,
title = {Enhanced antileukemic effect of NKp30b isoform of donor-derived NK cells infused after HLA-haploidentical allogeneic hematopoietic cell transplantation in high-risk AML and MDS.},
author = {Choi EJ and Lee HH and Yoon SR and Choi I and Park H and Park HS and Choi Y and Lee JH and Lee JH and Kim HS and Lee KH},
year = {2025},
journal = {Bone marrow transplantation},
doi = {10.1038/s41409-025-02518-0},
url = {https://doi.org/10.1038/s41409-025-02518-0}
}RIS
TY - JOUR TI - Enhanced antileukemic effect of NKp30b isoform of donor-derived NK cells infused after HLA-haploidentical allogeneic hematopoietic cell transplantation in high-risk AML and MDS. AU - Choi EJ AU - Lee HH AU - Yoon SR AU - Choi I AU - Park H AU - Park HS AU - Choi Y AU - Lee JH AU - Lee JH AU - Kim HS AU - Lee KH PY - 2025 JO - Bone marrow transplantation DO - 10.1038/s41409-025-02518-0 UR - https://doi.org/10.1038/s41409-025-02518-0 ER -
APA
EJ, C., HH, L., SR, Y., I, C., H, P., HS, P., Y, C., JH, L., JH, L., HS, K., & KH, L. (2025). Enhanced antileukemic effect of NKp30b isoform of donor-derived NK cells infused after HLA-haploidentical allogeneic hematopoietic cell transplantation in high-risk AML and MDS.. Bone marrow transplantation. https://doi.org/10.1038/s41409-025-02518-0
Source records
- pubmed · retrieved 2026-09-25T14:25:28.480Z